Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP7 | P09237 | 4/20 | 0.55 |
| ▸ | MMP10 | P09238 | 1/20 | 0.55 |
| ▸ | MMP9 | P14780 | 1/20 | 0.55 |
| ▸ | MMP13 | P45452 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | PSMB8 | P28062 | 2/20 | 0.44 |
| ▸ | PSMB5 | P28074 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7417214 | 0.90 | MMP7 (0.61) | MMP7MMP10MMP9MAPTALDH1A1 | |
| SCHEMBL7416941 | 0.89 | MMP7 (0.55) | MMP7MMP10MMP9 | |
| SCHEMBL7418330 | 0.89 | MMP7 (0.58) | MMP7MMP10MMP9MAPTALDH1A1 | |
| SCHEMBL7415030 | 0.89 | MMP7 (0.63) | MMP7MMP10MMP9ALDH1A1 | |
| SCHEMBL7414577 | 0.86 | MMP7 (0.49) | MMP7MMP10MMP9MMP13 | |
| SCHEMBL7423497 | 0.85 | MMP7 (0.61) | MMP7MMP10MMP9MAPTPSMB8 | |
| SCHEMBL7417269 | 0.85 | MMP7 (0.55) | MMP7MMP10MMP9 | |
| SCHEMBL7417000 | 0.85 | MMP7 (0.63) | MMP7MMP10MMP9MMP13MAPT | |
| SCHEMBL7411989 | 0.84 | MMP7 (0.49) | MMP7MMP10MMP9MMP13 | |
| SCHEMBL8006415 | 0.84 | MMP7 (0.70) | MMP7MMP10MMP9MMP13ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6218389-B1 | FOR THERAPY AND PROPHYLAXIS OF ARTHRITIS, CANCER, CARDIOVASCULAR DISORDERS; SKIN DISORDERS; OCULAR DISORDERS; INFLAMMATION AND GUM DISEASES, MULTIPLE SCLEROSIS, CACHEXIA, PREVENTING LOOSENING OF PROSTHETIC DEVICES | THE PROCTER & GAMBLE CO. | 2001-04-17 | — | — | US | disclosed |
| EP-1009737-A2 | SULFONYLAMINO SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEASE INHIBITORS | THE PROCTER & GAMBLE COMPANY (US) | 2000-06-21 | — | — | EP | disclosed |
| WO-1999006340-A2 | SULFONYLAMINO SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEASE INHIBITORS | THE PROCTER & GAMBLE COMPANY (US) | 1999-02-11 | — | — | WO | disclosed |